Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Purpose. To determine the efficacy of intravitreal ranibizumab injection as adjuvant therapy in the treatment of neovascular glaucoma (NVG) accompanied by postvitrectomy diabetic vitreous hemorrhage (PDVH). Methods. Eighteen NVG patients (18 eyes) accompanied by PDVH were enrolled in this prospectiv...
Main Authors: | Xi Shen, Yanwei Chen, Yanuo Wang, Lu Yang, Yisheng Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2016/4108490 |
Similar Items
-
Intravitreal ranibizumab as adjuvant treatment for neovascular glaucoma
by: Flavia Gazze Ticly, et al.
Published: (2013-04-01) -
Clinical observation on the treatment of neovascular glaucoma with intravitreal Ranibizumab injection combined with vitrectomy, panretinal photocoagulation and trabeculectomy
by: Rui-Feng Su, et al.
Published: (2020-08-01) -
Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage
by: Xiu-Juan Li, et al.
Published: (2015-01-01) -
Intravitreal Ranibizumab injection combined with trabeculectomy and PRP for neovascular glaucoma
by: Sheng-Fu Yang, et al.
Published: (2018-12-01) -
Ranibizumab combined with vitrectomy for DR with neovascular glaucoma
by: Hui Jiang, et al.
Published: (2019-06-01)